Skip to main content Help with accessibility Skip to main navigation

FILGOTINIB tablets (Jyseleca®▼) for moderate to severe rheumatoid arthritis

CCG Approval Status:

Date Added: 25 - Mar - 2021
Body System:
Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of FILGOTINIB tablets (Jyseleca®▼), by specialists only, for moderate to severe rheumatoid arthritis in accordance with NICE TA676.